TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The week’s reported beauty-industry developments included Galderma’s agreed $1.5 billion acquisition of ZO Skin Health, international retail expansion and new manufacturing and sustainability investments. Legal disputes, China customs delays and calls for stronger UK aesthetics regulation also featured; several reported plans and allegations remain subject to further detail.
Beauty companies and retailers reported a busy week of acquisitions, financial results and international expansion, while legal disputes and trade pressures added risks across the sector, according to Global Cosmetics News’ Week 42 review. The reported developments included Galderma’s agreed $1.5 billion acquisition of ZO Skin Health, expansion of K-beauty distribution and customs delays affecting French cosmetics exporters in China.
Corporate transactions and restructuring were among the week’s leading developments. Galderma agreed to acquire physician-dispensed skincare brand ZO Skin Health for $1.5 billion. Bogart sold its 47-store Israeli cosmetics retail subsidiary for €5.8 million. Separately, the European Union approved Kimberly-Clark’s proposed $40 billion acquisition of Kenvue following a divestment agreement, according to the review. Amazon was also reported to be in discussions to acquire AI start-up Decart for about $7 billion, a technology deal outside the beauty sector.
Financial and retail reports pointed to growth in several parts of the market. LVMH reported higher third-quarter sales across its beauty operations and Sephora network. Shein said its UK sales rose 26% to £2.58 billion, surpassing Asos. e.l.f. Beauty said it planned to put a $50 million tariff refund toward pricing and marketing initiatives. The review also reported that Beauty Tech Group executives sold £6 million in shares after the company’s strong initial public offering performance.
International distribution and investment also featured. CJ Olive Young expanded K-beauty distribution through Sephora stores in Southeast Asia and Hong Kong, while Nykaa and L’Oréal introduced a Kiehl’s skincare launch in India. Kiko Milano set out plans to double its Indian retail footprint by the end of 2026. Estée Lauder invested €5.7 million in advanced manufacturing at its Belgian facility, and L’Oréal Travel Retail partnered with Avolta on sustainability initiatives in duty-free beauty.
Deals and Expansion Reshape Beauty
The developments show companies pursuing different ways to grow and manage risk: buying or selling brands and stores, expanding into new markets, and investing in production and digital engagement. For consumers, these moves could affect where products are available, how brands are marketed and whether companies adjust prices. The review does not establish that any announced plan has already changed consumer prices or store access.
Trade friction and legal challenges carry potential costs for businesses operating across borders. A lawsuit over alleged unauthorised sales and customs delays can create uncertainty around distribution and brand rights. The review does not report the outcome of the dispute or quantify the commercial effect of the delays.
As an affiliate, we earn on qualifying purchases.
A Week Across Global Markets
The review grouped developments across beauty, personal care, retail and adjacent technology. Some were completed actions or reported results, while others were agreements, discussions or plans. That distinction matters: an acquisition agreement is not the same as a completed transaction, and a stated expansion target does not establish that new stores have opened.
Other items concerned marketing, leadership and industry standards. e.l.f. Cosmetics launched a virtual beauty experience on ZEPETO, while an AI-generated concept involving Hunter and Rhode Beauty prompted questions about unofficial brand collaborations and generative technology. Bandai expanded Tamagotchi cosmetics licensing in Asian markets. The review also reported executive changes at Gap Inc., ELEMIS, Bluemercury and Isamaya Ffrench’s namesake brand, alongside updated model-protection standards from Kering and LVMH.
As an affiliate, we earn on qualifying purchases.
Deal Status and Disputes
The supplied review does not give completion dates or closing conditions for the Galderma–ZO Skin Health agreement, nor details of the divestment tied to EU approval of Kimberly-Clark’s Kenvue acquisition. Amazon’s reported discussions with Decart are not described as a signed agreement. The review also provides no direct statements from the companies involved to clarify those reports.
Shiseido’s €2.6 million case against Shein concerns alleged unauthorised cosmetics sales; the allegation is not a finding of wrongdoing, and no ruling is reported. The review does not specify which customs procedures caused delays for French exporters in China, how long they lasted or whether they have been resolved. Further details on the UK aesthetics regulation proposal and the future of Isamaya Ffrench’s brand are also absent.
As an affiliate, we earn on qualifying purchases.
Pending Deals and Market Plans
Attention will turn to whether the announced transactions proceed and whether the planned expansions meet their stated targets. Kiko Milano’s goal is to double its Indian retail footprint by the end of 2026; the review does not give a store count or interim timetable. Galderma’s proposed purchase and the Kenvue transaction also require readers to distinguish reported agreements and regulatory approval from completed ownership changes.
Updates on the Shiseido-Shein litigation, Chinese customs delays and calls for tighter UK aesthetics oversight could clarify how legal and policy pressures affect beauty companies. The review gives no dates for those developments, so their timing and outcomes remain open.
As an affiliate, we earn on qualifying purchases.
Key Questions
What was the main development in the Week 42 review?
The review covered a range of developments, including Galderma’s agreed $1.5 billion purchase of ZO Skin Health, retail expansion and manufacturing investment, as well as trade and legal pressures.
Did Galderma complete its acquisition of ZO Skin Health?
The source says Galderma agreed to acquire the brand. It does not say the transaction has closed or provide a completion date.
What legal dispute was reported?
Shiseido filed a €2.6 million lawsuit against Shein over alleged unauthorised cosmetics sales. The review reports no court ruling, so the allegation should not be treated as established wrongdoing.
What expansion plans were reported for India?
Kiko Milano said it plans to double its Indian retail footprint by the end of 2026. Nykaa and L’Oréal also strengthened Kiehl’s presence with a new skincare launch, according to the review.
What remains unresolved?
The review does not provide the status of the proposed acquisitions, the outcome of the Shiseido-Shein case, details on China customs delays or a timetable for possible UK aesthetics regulation.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
